SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-016941
Filing Date
2017-03-16
Accepted
2017-03-16 07:10:35
Documents
3
Period of Report
2017-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-8417_18k.htm 8-K 27725
2 EX-99.1 a17-8417_1ex99d1.htm EX-99.1 11162
3 GRAPHIC g84171mmi001.gif GRAPHIC 4244
  Complete submission text file 0001104659-17-016941.txt   46240
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 17692866
SIC: 2834 Pharmaceutical Preparations